SCHEMBL8180481

SCHEMBL8180481

CCOC(=O)CCCC1CCN(CCC=C2c3ccccc3CCc3ccccc32)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.43
HRH1 P35367 5/20 0.43
DRD3 P35462 5/20 0.43
HRH3 Q9Y5N1 2/20 0.43
DRD1 P21728 1/20 0.43
HTR4 Q13639 2/20 0.43
CHRM1 P11229 6/20 0.42
CHRM2 P08172 4/20 0.42
CHRM4 P08173 4/20 0.42
CHRM5 P08912 4/20 0.42
CHRM3 P20309 4/20 0.42
DRD4 P21917 4/20 0.42
ADRA1D P25100 2/20 0.42
ADRA1A P35348 2/20 0.42
ADRA1B P35368 2/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
ADRB2 P07550 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8187171 0.94 SIGMAR1 (0.43) DRD2HRH1DRD3HRH3DRD1
SCHEMBL7603903 0.86 HRH1 (0.47) DRD2HRH1DRD3HRH3CHRM1
Oxalic Acid SCHEMBL8180902 0.84 HRH1 (0.45) DRD2HRH1DRD3HRH3CHRM1
SCHEMBL8182524 0.84 HRH1 (0.43) DRD2HRH1DRD3DRD1HTR4
SCHEMBL8187207 0.83 HRH1 (0.42) DRD2HRH1DRD3HRH3DRD1
Hydrochloric Acid SCHEMBL6956807 0.83 KDM4E (0.53)
SCHEMBL8173072 0.82 SIGMAR1 (0.42) DRD2HRH1HTR4CHRM1CHRM2
SCHEMBL8181729 0.82 SIGMAR1 (0.60) DRD2HRH1DRD3DRD1HTR4
SCHEMBL7609166 0.81 HRH1 (0.48) HRH1DRD3HRH3CHRM1SIGMAR1
Hydrochloric Acid SCHEMBL8182026 0.81 HRH1 (0.47) HRH1CHRM1SIGMAR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114354-A N-substituted azaheterocyclic compounds NOVO NORDISK A/S (DK) 2000-09-05 US disclosed
US-6100253-A 3-(1-(3-(XANTHEN-9-YLIDENE)-1-PROPYL)PIPERIDIN-4-YL)PROPIONIC ACID, FOR EXAMPLE; TREATING NON-INSULIN DEPENDENT DIABETES, NEUROGENIC INFLAMMATION AND OBESITY; INTERFERE WITH C-FIBERS TO INHIBIT SECRETION OF INSULIN ANTAGONISING PEPTIDES NOVO NORDISK A/S (DK) 2000-08-08 US disclosed
US-6066632-A ANALGESICS; ANTIINFLAMMATORY AGENTS NOVO NORDISK A/S (DK) 2000-05-23 US disclosed
EP-0991621-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 2000-04-12 EP disclosed
US-6040318-A TREATING INSULIN RESISTANT NON-INSULIN-DEPENDENT DIABETES MELLITUS AND AGEING-ASSOCIATED OBESITY, NEUROGENIC INFLAMMATION ASSOCIATED WITH NEUROPATHY OR RHEUMATOID ARTHRITIS NOVO NORDISK A/S (DK) 2000-03-21 US disclosed
WO-1999000367-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1999-01-07 WO disclosed